Open innovation, co-construction and sharing
Time of Update: 2022-09-10
China Chamber of Commerce and Hong Kong Fung Group Li & Fung Research Center have released the top ten hotspots in Chinese business for 15 consecutive years .
The new vanadium catalyst of nanhua institute has gone abroad
Time of Update: 2022-09-07
NWS series vanadium catalyst for wet conversion is a new type of special vanadium catalyst developed by Nanhua Research Institute to adapt to the wet conversion sulfuric acid production process.
At the end of the year, the wave of mergers and acquisitions of pharmaceutical companies continued
Time of Update: 2021-12-26
In recent years, due to the difficulty, time-consuming, labor-intensive, and costly research and development of new drugs, many pharmaceutical companies have vigorously made some new investment arrangements in order to increase corporate operating profits, enrich drug pipelines, and reduce R&D expenditures .
Sulfuric acid titanium dioxide process builds a circular chain
Time of Update: 2021-09-23
During the "Thirteenth Five-Year Plan" period, the titanium dioxide industry should make a fuss about the clean production of sulfuric acid, vigorously implement the development strategy of circular economy, eat up resources, reduce consumption, and take the road of environmentally friendly development, especially to do a good job Three aspects of work:
2020 China International Coatings Expo and the 20th China International Coatings Exhibition
Time of Update: 2021-07-20
), co-organized by Beijing TUBO International Exhibition Co.
The exhibition covers the entire coatings and related industrial chain fields, and has become a recognized brand in the coatings industry that integrates brand promotion, product display, information exchange, and business development.
Hao Junwei's team from Xuanwu Hospital discovers a new mechanism of neuroinflammation regulation after stroke丨Expert perspective
Time of Update: 2021-04-14
Introduction On March 26, 2021, the team of Professor Junwei Hao from the Department of Neurology, Xuanwu Hospital of Capital Medical University published a research paper entitled "Microglial PGC-1α protects against ischemicbrain injury by suppressing neuroinflammation" in Genome Medicine (IF: 10.
Pfizer obtains commercial rights and interests of cresemba in Europe
Time of Update: 2017-06-16
Source: Sina Pharmaceutical Co., Ltd June 14, 2017, Pfizer and Basilea, a Swiss anti infective and anti-tumor drug R & D enterprise, said that they had reached a license agreement on the exclusive com